← All indications
Enterocolitis
Inflammation of the MUCOSA of both the SMALL INTESTINE and the LARGE INTESTINE. Etiology includes ISCHEMIA, infections, allergic, and immune responses.
Subtype terms (3)
More specific conditions that are subtypes of Enterocolitis in the MeSH hierarchy.
- Enterocolitis, Necrotizing
65 drugs (34 approved, 31 experimental)
- Enterocolitis, Neutropenic
2 drugs (1 approved, 1 experimental)
- Enterocolitis, Pseudomembranous
14 drugs (10 approved, 4 experimental)
Drugs by status
Approved for this indication (2)
Phase 4 trials (6)
Phase 2 trials (3)
Phase 1 trials (1)
Other trials (1)
Organizations
Organization Involved with Phase 4 Indications (14)
Organization Involved with Phase 3 Indications (22)
- Genzyme
- Infant Bacterial Therapeutics
- National Institutes of Health (NIH)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- University of Pennsylvania
- University of Pittsburgh
- Chulalongkorn University
- Johns Hopkins University
- McMaster University
- Sylhet M.A.G.Osmani Medical College
- University of Florida
- University of Sydney
- University of Alberta
- Aga Khan University
- University of Calgary
- University of California, Los Angeles
- Zeynep Kamil Maternity and Childen Education and Training Hospital
- Zekai Tahir Burak Hospital
- Stellenbosch University
- Bill and Melinda Gates Foundation
- United States Agency for International Development
- The Physicians' Services Incorporated Foundation
Organization Involved with Phase 2 Indications (26)
- Novartis
- BioGaia AB
- Leadiant Biosciences, Inc.
- Rebiotix Inc.
- The EMMES Corporation
- Burnasyan Federal Medical Biophysical Center
- Bnai Zion Medical Center
- Duke University
- Instituto Mexicano del Seguro Social
- Ostergotland County Council, Sweden
- Universidad de Guanajuato
- University of Michigan
- Wayne State University
- Zhengzhou University
- University of Chicago
- University of Copenhagen
- Government of Mexico
- University of Guanjuato
- Hebrew University
- University of Gothenburg
- Linkoping University
- The Ekhaga Foundation, Stockholm, Sweden
- China Medical University
- Medical Research Council, Sweden
- Women and Children Health Care Center of Luoyang, China
- The Children Complex & The Institute of Child Health, Multan
Organization Involved with Phase 1 Indications (3)
Organization Involved with Other Experimental Indications (30)
- Region Syddanmark
- Dr. Sami Ulus Children's Hospital
- Central South University
- Alexandra Hospital, Athens, Greece
- Maternal and Child Health Hospital of Foshan
- Nanjing Medical University
- Northwestern University
- Shenzhen Bao'an Maternal and Child Health Hospital
- University of Nebraska
- University of Southern Denmark
- University of Toronto
- University of Athens
- Wake Forest University
- Fudan University
- Tel Aviv University
- Uppsala University
- University of Ankara
- Jiao Tong University
- Shanghai University
- Jinan University
- University of the Witwatersrand
- National University of Singapore
- Sun Yat-Sen University
- Washington University in St. Louis
- Shenzhen University
- Shantou University
- Uppsala County Council, Sweden
- Nestle
- St. Justine's Hospital
- Future University in Egypt